Peripheral Nerve Injuries Market to Show Remarkable Growth at a CAGR of 6.19% by 2034 | DelveInsight [Yahoo! Finance]
Sonnet BioTherapeutics Holdings, Inc. (SONN)
Company Research
Source: Yahoo! Finance
in medical technology, increasing awareness and diagnosis, and rising healthcare expenditure in the forecast period (2024–2034). LAS VEGAS Nov. 18, 2024 /PRNewswire/ -- DelveInsight's Peripheral Nerve Injuries Market Insights report includes a comprehensive understanding of current treatment practices, peripheral nerve injuries emerging drugs/devices, market share of individual therapies/devices, and current and forecasted market size from 2020 to 2034, segmented into 7MM [ the United States , the EU4 ( Germany France Italy , and Spain ) and the United Kingdom , and Japan]. Key Takeaways from the Peripheral Nerve Injuries Market Report According to DelveInsight's analysis, the market size for peripheral nerve injuries was found to be USD 2.4 billion in the 7MM in 2023. In 2023, the annual number of peripheral number injuries of upper extremities in the 7MM were 2.9 million , and of lower extremities were 1.1 million Surgical treatment aims to repair the damaged nerve, maximi
Show less
Read more
Impact Snapshot
Event Time:
SONN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SONN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SONN alerts
High impacting Sonnet BioTherapeutics Holdings, Inc. news events
Weekly update
A roundup of the hottest topics
SONN
News
- Sonnet BioTherapeutics Provides Fiscal Year 2025 First Quarter Business and Earnings Update [Yahoo! Finance]Yahoo! Finance
- Sonnet BioTherapeutics Appoints Stephen McAndrew, Ph.D. as Chief Business Officer [Yahoo! Finance]Yahoo! Finance
- Sonnet BioTherapeutics Appoints Stephen McAndrew, Ph.D. as Chief Business OfficerGlobeNewswire
- Sonnet BioTherapeutics Provides Fiscal Year 2025 First Quarter Business and Earnings UpdateGlobeNewswire
- Sonnet BioTherapeutics Further Expands Global Intellectual Property Portfolio with Issuance of EU Patent for FHAB® Platform TechnologyGlobeNewswire
SONN
Analyst Actions
- 12/20/24 - Chardan Capital
SONN
Sec Filings
- 2/13/25 - Form 10-Q
- 2/13/25 - Form 8-K
- 2/3/25 - Form EFFECT
- SONN's page on the SEC website